Results 251 to 260 of about 138,032 (344)
Immune Thrombocytopenia Associated with COVID-19 - Case Series
Ramil Fatkhullin, Vasily Shuvaev
openalex +2 more sources
Abstract Background Annually millions of platelet concentrate (PC) are transfused worldwide. The decision regarding PC transfusion is often complex; therefore, the implementation of a hospital programme designed to streamline and facilitate the decision‐making process is beneficial. Such a programme helps standardise transfusion practices, ensures that
Piotr F. Czempik +2 more
wiley +1 more source
The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients [PDF]
Marek Kos +7 more
openalex +1 more source
Abstract Background Reports on the safety and efficacy of combination heparin and citrate anticoagulation with cell therapy collections in adults are limited. There are no reports on the use of this combination in healthy allogeneic adult donors undergoing cell therapy collection. This retrospective analysis is the first study to examine its safety and
Jiahao Zhang +6 more
wiley +1 more source
Thrombocytopenia, immune thrombocytopenia and idiopathic thrombocytopenic purpura
Sinasi Ozsoylu
doaj
Antigen B from Echinococcus granulosus regulates autophagy-mediated macrophage polarization to alleviate immune thrombocytopenia. [PDF]
Song HC +7 more
europepmc +1 more source
Abstract Background Immunomodulatory consequences of transfusion, known as transfusion‐related immune modulation (TRIM), impact patients but are not captured by hemovigilance systems. This study's objective is to explore TRIM impacts of production changes made by the blood supplier. Methods We included all transfused and non‐transfused adult inpatients
S. Ning +15 more
wiley +1 more source
Predictors of response to emergent therapies in paediatric immune thrombocytopenia. [PDF]
O'Farrell C +7 more
europepmc +1 more source

